David L. Corbet

Keine laufenden Positionen mehr

70 Jahre

Health Technology

Profil

David L.
Corbet has been President, Chief Operating Officer and a Director of Matritech, Inc. since October 1993.
He joined Matritech as Executive Vice President in April 1993.
Prior to joining Matritech, Mr. Corbet was President and Chief Operating Officer of T Cell Diagnostics, Inc. from 1991 to April 1993.

Ehemalige bekannte Positionen von David L. Corbet

Unternehmen	Position	Ende
MZT Holdings, Inc. MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA.	Direktor/Vorstandsmitglied	20.06.2012
Matritech, Inc. Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services	Präsident	-

Sehen Sie sich die Erfahrung von David L. Corbet im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David L. Corbet im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Matritech, Inc. Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services	Health Technology
MZT Holdings, Inc. MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA.	Health Technology